150 results about "Motor nerve" patented technology

Apparatus and methods for performing spinal disc lesioning procedures while monitoring the temperature near the spinal nerve roots. A needle containing a thermocouple and an injection bore may be placed between the disc and a nerve root. Temperature near the nerve root may be monitored during the lesioning procedure and if raised to a point where damage to the nerve could occur, the procedure may be stopped before damage is done. Coolant may be injected through the injection bore to lower the temperature near the nerve root. Additional dual purpose needles may be placed on the disc adjacent the opposite nerve root or in the spinal canal at the level of the disc for additional control. A hollow, flexible tip electrode needle may be used to repair and lesion the disc tissue. Prior to lesioning, the electrode may be stimulated to assess motor nerve response and avoid motor nerve damage.

The present invention relates to methods and apparatuses for the detection of neural or muscular activity, analysis of the signals and the subsequent stimulating of neural or muscular tissue based thereon. According to a first aspect of the invention an apparatus for producing a muscular action is provided, comprising a combined sensing and stimulation electrode device comprising at least one neurosense electrode means capable of sensing a nerve signal from a peripheral nerve and at least one stimulation electrode means capable of stimulating a peripheral motor nerve fiber, means for receiving and processing the sensed neurosignals to identify a signal indicative of a specific action, especially a component of the gait performed by the patient and for producing a control signal in response thereto, and means for operating the at least one stimulation electrode means in response to the control signal to produce a stimulation of a peripheral motor nerve fiber.

Medical devices, systems, and methods for pain management and other applications may apply cooling with at least one probe inserted through an exposed skin surface of skin. The cooling may remodel one or more target tissues so as to effect a desired change in composition of the target tissue and / or a change in its behavior, often to interfere with transmission of pain signals along sensory nerves. Alternative embodiments may interfere with the function of motor nerves, the function of contractile muscles, and / or some other tissue included in the contractile function chain so as to inhibit muscle contraction and thereby alleviate associated pain. In some embodiments, other sources of pain such as components of the spine (optionally including herniated disks) may be treated.

Apparatus and method for making and using devices that generate optical signals, and optionally also electrical signals in combination with one or more such optical signals, to stimulate (i.e., trigger) and / or simulate a sensory-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to treat nerve damage in the peripheral nervous system (PNS) or the central nervous system (CNS) and provide sensations to stimulate and / or simulate “sensory” signals in nerves and / or brain tissue of a living animal (e.g., a human) to treat other sensory deficiencies (e.g., touch, feel, balance, visual, taste, or olfactory) and provide sensations related to those sensory deficiencies, and / or to stimulate (i.e., trigger) and / or simulate a motor-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to control a muscle or a robotic prosthesis.

The invention relates to a combined type bionic quadruped robot controller, which is in a structure similar to a vertebrate nervous system, wherein the controller is divided into a decision layer, a planning layer and an execution layer which respectively correspond to a higher nervous center, a lower nervous center and a motor nerve of an animal. The decision layer for realizing that the robot senses the working environment and generates corresponding motion decision instructions consists of an ARM9 (advanced RISC (reduced instruction-set computer) machine 9) and an environmental information acquisition system, and a real-time operating system is embedded in the ARM9. The core of the planning layer is a walking pattern generator, and is used for planning and solving the motion parameters of each joint according to the decision instructions from the upper layer. The execution layer for controlling the current, the position and the speed of a driving motor in three closed loops consists of a motor controller using a digital signal processor as the core. Data can be effectively transmitted among the three layers in real time through a dual-port RAM (random-access memory) and a CAN (controller area network) bus network. The combined type bionic quadruped robot controller disclosed by the invention has the characteristics of high reliability, high flexibility, extension easiness and maintenance easiness, and has a broad application prospect in the technical field of bionic legged robots.

A method for cryogenically treating a target tissue comprises providing a cryogenic device having one or more tissue penetrating needle probes, and advancing the one or more tissue penetrating needle probes through skin disposed above the target tissue into the target tissue. The target tissue comprises a motor nerve. The method also includes cooling the target tissue with the one or more tissue penetrating needle probes, and temporarily disrupting signal conduction from the motor nerve thereby preventing contraction of a muscle operably coupled to the motor nerve. This reduces or eliminates hyperdynamic wrinkles of a patient's face.

Apparatus and method for making and using devices that generate optical signals, and optionally also electrical signals in combination with one or more such optical signals, to stimulate (i.e., trigger) and / or simulate a sensory-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to treat nerve damage in the peripheral nervous system (PNS) or the central nervous system (CNS) and provide sensations to stimulate and / or simulate “sensory” signals in nerves and / or brain tissue of a living animal (e.g., a human) to treat other sensory deficiencies (e.g., touch, feel, balance, visual, taste, or olfactory) and provide sensations related to those sensory deficiencies, and / or to stimulate (i.e., trigger) and / or simulate a motor-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to control a muscle or a robotic prosthesis.

The invention discloses a mirror movement neuromodulation system, which comprises a plurality of lead biological signal amplifiers, a microcomputer controller, a plurality of lead functional electric stimulators and a micro-current direct-current constant-current stimulator. The principle that functional electric stimulation and transcranial direct-current electric stimulation techniques and mirror movement neurons participate in movement control is applied comprehensively, the biological signal amplifiers, the functional electric stimulators for simulating integrated electromyography envelope signal control, and the micro-current direct-current constant-current stimulator are integrated through the microcomputer controller, myoelectric activity envelope signals are generated by processing myoelectric signals of a plurality of muscle groups which move functionally by using an uninjured side limb, and the plurality of functional electric stimulators are modulated and controlled, so that the same mirror action is generated by the plurality of muscle groups of an injured limb on an opposite side according to uninjured side myoelectric information, brain functional regulation and reconstruction are realized, the plasticity of neuronal synapsis and the recovery of neurological functions are facilitated, and the treatment effect of sports rehabilitation is achieved.

The present invention relates to an agent for protecting a motor nerve of a patient with amyotrophic lateral sclerosis, which comprises a combination of (a) (2R)-2-propyloctanoic acid or a salt thereof and (b) a therapeutic agent for amyotrophic lateral sclerosis such as riluzole. An agent comprising a combination of (a) (2R)-2-propyloctanoic acid which is orally administered once a day in an amount per dose of about 1200 mg and (b) riluzole which is orally administered twice a day in an amount per dose of about 50 mg is useful for protecting a motor nerve in a patient(s) with amyotrophic lateral sclerosis. The agent can also suppress the respiratory disability associated with the progression of the disease condition and improve the survival rate of the patient(s).

The invention relates to a composite of active ingredients of Chinese herb medicine used for preventing the damage of cerebral ischemia and relevant diseases, in particular to a preparation which is prepared by the active ingredients of the Chinese herb medicine; the preparation is prepared by the active ingredients of the Chinese herb medicine and the conventional preparation technique which is used by carriers permitted by pharmacy, and comprises the following components with the parts by weight: 2 to 10 parts of ginsenoside Rb, 2 to 10 parts of ginsenoside Rg1, 1 to 5 parts of ginsenoside Rd, 1 to 5 parts of ginsenoside Re, 2 to 10 parts of stilbene glycoside, 1 to 5 parts of ginkgolide and 1 to 5 parts of flavonoid mixture which consists of kaempferol and quercetin with the weight rate to be 1:1. The invention has the advantages that the defects that in the traditional compounded Chinese medicine, the composition is complex, the product quality is not controlled effectively and the curative effect is not stable are overcome, has clear ingredients, definite effect, stable quality and obvious control effect on ischemic stroke, sequela, cerebral arteriosclerosis and vascular dementia, can improve the functions of motor nerve, and learning and memory of the patients, has low toxicity and simple preparation method without obvious side effect and is suitable for industrial mass production.

The invention discloses a quaternary ammonium salt compound and a preparation method and application thereof. The invention provides a compound shown in a formula I with a novel structure, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, or a solvate thereof, or a prodrug thereof, or a metabolite thereof. The compound has the advantages of rapid onset of action, long-termlocal anesthesia effect after single administration, sensory nerve block time greater than motor nerve block time, and both long-term local anesthesia effect and selective local anesthesia effect, remarkably reduces side effects of QX314 and QX314 compositions and quaternary ammonium salt compounds with surfactant structural characteristics, and has better safety. Namely, the compound of formula Iand the pharmaceutically acceptable salt thereof can be used for preparing safe drugs with long-term local anesthesia and selective local anesthesia effects, and have the advantages of long-term local anesthesia, good local anesthesia selectivity, less nerve damage and high safety.

Apparatus and method for making and using devices that generate optical signals, and optionally also electrical signals in combination with one or more such optical signals, to stimulate (i.e., trigger) and / or simulate a sensory-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to treat nerve damage in the peripheral nervous system (PNS) or the central nervous system (CNS) and provide sensations to stimulate and / or simulate “sensory” signals in nerves and / or brain tissue of a living animal (e.g., a human) to treat other sensory deficiencies (e.g., touch, feel, balance, visual, taste, or olfactory) and provide sensations related to those sensory deficiencies, and / or to stimulate (i.e., trigger) and / or simulate a motor-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to control a muscle or a robotic prosthesis.

The invention discloses an abnormal gait detection method based on a determined learning theory. The abnormal gait detection method based on the determined learning theory includes the steps that features are extracted, neural network modeling and identification are dynamically carried out on a gait system of healthy and normal people and patients with motor neurodegenerative diseases of different types on the basis of the extracted gait features, a constant neural network is built, a dynamic estimator is built by the utilization of the constant neural network, and abnormal gaits caused by the motor neurodegenerative diseases are distinguished from normal gaits of the general healthy people according to the minimum error principle on the basis of differences between the gait mode of the healthy and normal people and the gait mode of the patients with the motor neurodegenerative diseases of different types on the gait system dynamics, so that the abnormal gaits are detected accurately and a detection result is evaluated. The abnormal gait detection method based on the determined learning theory has the advantages that the method is convenient and easy to implement and is in a non-invasion mode, and under the intelligent home environment, daily gait monitoring on family members can be achieved by mounting a pressure sensing floor system or wearing special shoes with sensor insoles.

The invention relates to a preparation method of ropivacaine mesylate injection packed by a soda-lime glass bottle, which comprises the following processing steps of ingredient preparation, liquor preparation, soda-lime glass bottle and rubber plug cleaning, filling, capping, sterilization, lamp test, labeling, packing and finished product inspection. The injection is subject to a filtration sterilization processing step once and a flowing steam sterilization processing step once, wherein microorganisms larger than 0.22 microns in liquid medicine are removed by a filter method, microorganismssmaller than 0.22 microns are killed by flowing steam sterilization, and insoluble particles in the liquid medicine are removed during filtration sterilization simultaneously, thereby greatly reducingthe occurrence of phlebitis; and the invention is packed by the soda-lime glass bottle which has the advantages of heat resistance, acid and alkali resistance, large strength, and the like, thereby ensuring the stability of the medicine. Clinic comparison tests show that the ropivacaine mesylate injection packed by a soda-lime glass bottle has the advantages of quicker effect, long action time, reliable anesthetic effect, small toxicity to heart, separate blocking pf sensory and motor nerves, and the like, thereby being suitable for anesthesia in surgeries and postoperative analgesia.

Neural bridge devices for providing ionic communication across damaged or separated portions of a neuron, or between a neuron and an electronic device, are disclosed. The neural bridge devices can include an ionically conductive polymer that may functionally replace the biological conduction of action potentials along an axon, to restore sensory or motor nerve function, and may enhance neuronal healing.

The invention relates to a flexible nerve tract electrode, which comprises a flexible substrate, an electrode unit, an electrode lead, a lead welding spot and an insulating layer, wherein the electrode lead is electrically connected with the electrode unit and the lead welding spot; the electrode unit, the electrode lead and the lead welding spot form an electrode assembly together; the electrode assembly is arranged on the flexible substrate; the insulating layer is arranged on the flexible substrate and covers the electrode lead; and the electrode unit is electrically connected with a nerve tract. The invention also relates to a preparation method for the flexible nerve tract electrode. The flexible nerve tract electrode can be used for distinguishing moving nerve tracts and sensory nerve tracts in a nerve trunk, and can realize functions of a nerve cannula and provide space protection for growth of broken and injured nerves; functional electrical stimulation can be applied to the broken and injured nerves, so that the growth of the broken and injured nerves is accelerated; and the repair state of the broken and injured nerves can be monitored in real time by acquiring electrical physiological information at two ends of the broken and injured nerves. Moreover, the flexible nerve tract electrode can also be used for acquiring nerve information of normal nerve tracts to realize intelligent control of external instruments.

The guide objects 40L and 40R instruct the movements of the respective left and right hands. The image sensor 54 captures images of the input instruments 3L and 3R which are worn on left and right hands respectively and the cursors 70L and 70R are connected with the movements of the input instruments 3L and 3R by processing the result of the imaging. A series of the processing and transmission of information in the order of the eyes, the visual nerve, the brain, the motor nerve, and the hands and arms are performed inside of a human body, which are not performed in a normal life, by making the operator perform the independent motions of the respective left and right hands, which are not performed in a normal life.

Methods for providing nutrition and for enhancing neurological development of preterm infants are disclosed. Also disclosed is an improved nutritional composition containing specified amounts of DHA and AA as well as their precursor essential fatty acids alpha-linolenic and linoleic acids. The methods involve feeding LCP supplemented, nutrient-enriched formulas for an extended feeding regimen, typically until at least 3 months corrected age (CA), preferably to 6 or even 12 months CA. The neurological developments, for example, visual development, motor development and language development were enhanced without findings of anthropometric growth faltering or inhibition.

Apparatus for producing a dorsiflexion of the foot of a patient comprises a combined sensing and stimulation electrode device having neurosense and stimulation electrode means capable of sensing a nerve signal from a peripheral nerve and stimulating peripheral motor nerve fibres. The neurosense and stimulation electrode means are implantable above the knee of a patient. Means for receiving and processing the sensed nerve signals are provided to identify a signal indicative of the timing of hell strike and heel lift of the patient and for producing a control signal in response thereto. Means for operating said neurosense and stimulation electrode means in response to the control signal to produce stimulation of the peripheral motor nerve fibres are also provided.

A surgical method for gastrocnemius muscle reduction is provided. The method may search for a motor nerve associated with a gastrocnemius muscle of a patient, inserts a probe by penetrating an epidermis around the motor nerve and locates a tip of the probe in the motor nerve, stimulates the motor nerve through supply of an electric signal to the probe, thereby shutting down the motor nerve.

A vaccine for reducing disease progression, and / or protection of motor nerve degeneration, and / or protection from glutamate toxicity in motor neurone disease (MND), particularly amyotrophic lateral sclerosis (ALS), patients, comprising an active agent selected from the group consisting of Cop 1, a Cop 1-related peptide, a Cop 1-related polypeptide, and poly-Glu, Tyr. The active agent is preferably Cop 1 or poly-Glu, Tyr, and can be administered with or without an adjuvant.

Apparatus and method for making and using devices that generate optical signals, and optionally also electrical signals in combination with one or more such optical signals, to stimulate (i.e., trigger) and / or simulate a sensory-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to treat nerve damage in the peripheral nervous system (PNS) or the central nervous system (CNS) and provide sensations to stimulate and / or simulate “sensory” signals in nerves and / or brain tissue of a living animal (e.g., a human) to treat other sensory deficiencies (e.g., touch, feel, balance, visual, taste, or olfactory) and provide sensations related to those sensory deficiencies, and / or to stimulate (i.e., trigger) and / or simulate a motor-nerve signal in nerve and / or brain tissue of a living animal (e.g., a human), for example to control a muscle or a robotic prosthesis.

Devices, systems and methods are provided for accessing and treating anatomies associated with a variety of conditions while minimizing possible complications and side effects. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, this involves stimulating portions of neural tissue of the central nervous system, wherein the central nervous system includes the spinal cord and the pairs of nerves along the spinal cord which are known as spinal nerves. In particular, some embodiments of the present invention are used to selectively stimulate portions of the spinal nerves, particularly one or more dorsal root ganglions (DRGs), to treat chronic pain while causing minimal deleterious side effects such as undesired motor responses. The present invention provides systems for positioning a lead near a spinal nerve, the systems comprising a lead, a sheath having a curved distal end and adapted to receive the lead therein, and a stylet configured to be posisitoned within a stylet lumen of the lead.

A method of monitoring relative nerve health and the presence of neuropraxia is described. The methods utilize the integration of a waveform function of an elicited or monitored nerve response to provide an indication of the strength of a detected signal from a nerve and thus the relative health and integrity of the nerve. In some embodiments motor nerve stimulation innervates muscle and an EMG waveform is obtained in response thereto. The integration under the waveform is expressed and an indexed value indicating a percentage of a certain threshold value. Methods set forth provide a more reliable status of a nerve in real-time and allow action to be taken to reduce neuropraxia or prevent permanent nerve damage.